Clinical Trials Overview
Clinical trials are research studies in which patients may volunteer to take part. Rutgers Cancer Institute of New Jersey uses clinical trials to find better ways to prevent, diagnose and treat cancer. As one of the National Cancer Institute’s designated cancer centers, the Cancer Institute of New Jersey is able to provide access to clinical trials not available at other hospitals, clinics or doctor’s offices, as well as access to some of the most advanced, targeted treatments and medicines available. The Cancer Institute of New Jersey is committed to providing the latest and best treatment options for cancer patients through clinical trials - outsmarting cancer with science.
All of today’s successful treatments for cancer are based on results of past clinical trials. Because of progress made through clinical trials, people treated for cancer are living longer today. The Cancer Institute currently enrolls approximately 17 percent of all its new adult cancer patients and approximately 70 percent of all pediatric cancer patients on clinical trials. Enrollment in clinical trials nationwide is fewer than five percent of all adult cancer patients.
- Visit the National Institutes of Health's "NIH Clinical Research Trials and You" website.
- Read the article entitled "The Importance of Cancer Clinical Trials"
- View the video below to learn how to understand cancer clinical trials.
Understanding Cancer Clinical Trials
Learn about clinical trials with CINJ's Eric Singer, MD, MA